BIOANCIENT: Cohort of Centenarians in Navarra (1926-1927)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age100+
SponsorFundacion Miguel Servet
About this trial
Demographic aging is a growing global challenge, driven by increasing life expectancy and declining birth rates, with projections indicating that more than 30% of the European population will be over 65 years old by 2100. Centenarians represent a unique biological model of extreme longevity, often exhibiting delayed onset of age-related diseases and preserved functional capacity.
This study aims to establish an intergenerational cohort of centenarians in Navarra (Spain) to investigate the biological, clinical, environmental, and lifestyle factors associated with extreme longevity. By integrating multidimensional data-including clinical assessments, functional and cognitive measures, and biological markers-this study seeks to improve understanding of aging mechanisms and identify potential determinants of healthy aging.
Eligibility criteria
Qualifiers
Individuals aged ≥100 years
Residents of Navarre, Spain
Disqualifiers
Clinical decompensation within the last month, including hemodynamic instability, acute illness, or hospitalization;
End-of-life condition, defined as a clinical state of irreversible deterioration with a life expectancy of days to weeks, as determined by a physician.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
333 Participants
are grouped into 1 trial groupSponsors and collaborators
Fundacion Miguel Servet
Lead sponsor
Gobierno de Navarra
Collaborator
Source ClinicalTrials.gov